DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Fox K, Ford I, Steg G, Tendera M. the BEAUTIFUL Investigators. on behalf of
Ivabradine for Patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial.
Lancet 2008; 372: 807-816
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.